Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.31 |
| ▸ | TRAP1 | Q12931 | 2/20 | 0.30 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24310408 | 1.00 | KDM4E (0.32) | KDM4EALDH1A1HSD17B10HSP90AA1HSP90AB1 | |
| SCHEMBL23851630 | 0.84 | KDM4E (0.36) | KDM4EALDH1A1HSD17B10HSP90AA1HSP90AB1 | |
| SCHEMBL29567765 | 0.84 | — | — | |
| SCHEMBL24310006 | 0.84 | — | — | |
| SCHEMBL15816170 | 0.78 | KDM4E (0.33) | KDM4EALDH1A1HSD17B10HSP90AA1HSP90AB1 | |
| SCHEMBL24310127 | 0.71 | ADORA2A (0.35) | KDM4EALDH1A1HSD17B10HSP90AA1HSP90AB1 | |
| SCHEMBL24310175 | 0.71 | ADORA2A (0.32) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL8190298 | 0.71 | KDM4E (0.32) | KDM4EALDH1A1HSD17B10HSP90AA1HSP90AB1 | |
| SCHEMBL24309578 | 0.71 | TRAP1 (0.30) | TRAP1HSP90B1 | |
| SCHEMBL7932046 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4225761-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2023-08-16 | — | — | EP | disclosed |
| EP-4225748-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |
| WO-2022076620-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |